NCT01971476 2018-07-30Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is KnownBoehringer IngelheimPhase 1 Completed22 enrolled 14 charts